CN Stock MarketDetailed Quotes

002727 Yixintang Pharmaceutical

Watchlist
  • 14.92
  • +0.44+3.04%
Not Open Dec 12 15:00 CST
8.89BMarket Cap56.95P/E (TTM)

Yixintang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-2.71%3.24B
15.85%3.6B
9.23%3.91B
4.67%3.68B
21.06%3.33B
61.85%3.11B
116.87%3.58B
57.11%3.51B
29.76%2.75B
-14.46%1.92B
Transactional financial assets
----
----
----
----
-40.65%8.36M
-97.34%8.36M
-98.68%8.36M
-97.19%8.36M
--14.08M
--314.44M
Notes receivable and accounts receivable
12.27%1.9B
18.21%1.89B
18.91%2.01B
-10.64%1.54B
-2.30%1.69B
-3.15%1.6B
-8.02%1.69B
28.00%1.73B
16.71%1.73B
37.50%1.65B
-Notes receivable
1,243.99%186.18M
7,476.99%300.73M
--48.63M
11,676.09%107.54M
--13.85M
--3.97M
----
--913.2K
----
----
-Accounts receivable
2.11%1.72B
-0.34%1.59B
16.04%1.96B
-16.82%1.44B
-3.10%1.68B
-3.39%1.6B
-8.02%1.69B
27.94%1.73B
16.71%1.73B
37.50%1.65B
Other receivables (including interest and dividends)
-5.03%338.73M
18.50%328.74M
16.01%331.78M
0.03%284.13M
18.53%356.69M
38.10%277.41M
45.79%285.99M
37.46%284.04M
36.93%300.92M
23.04%200.87M
-Dividend receivable
-49.15%780.77K
-56.75%780.77K
-23.80%780.77K
-23.80%780.77K
--1.54M
--1.81M
--1.02M
--1.02M
----
----
-Other receivable
----
19.00%327.96M
----
----
----
37.21%275.6M
----
36.97%283.02M
----
23.04%200.87M
Advance payment
34.77%195.21M
2.70%215.94M
-48.76%142.41M
-56.64%152.3M
-5.96%144.85M
-4.35%210.26M
57.87%277.91M
80.31%351.21M
4.98%154.03M
34.63%219.82M
Inventories
4.51%4B
3.24%3.97B
4.66%3.97B
13.73%3.85B
13.12%3.83B
14.16%3.85B
15.93%3.79B
2.12%3.39B
8.38%3.38B
27.54%3.37B
Receivable financing
-61.12%31.05M
46.33%65.13M
500.24%61.65M
-77.47%10.69M
98.94%79.85M
37.62%44.51M
-34.20%10.27M
82.89%47.44M
-52.87%40.14M
-2.89%32.34M
Non-current assets due within one year
----
--0
----
--219.66M
----
----
----
----
----
----
Other current assets
44.07%164.52M
24.42%157.73M
23.23%125.31M
10.26%153.54M
-0.40%114.19M
115.87%126.77M
61.70%101.69M
112.61%139.25M
-64.18%114.66M
-77.40%58.73M
Total current assets
3.31%9.87B
10.94%10.23B
8.25%10.55B
4.60%9.89B
12.52%9.55B
18.73%9.22B
24.27%9.74B
22.95%9.46B
13.23%8.49B
15.79%7.77B
Non Current assets
Other non-current financial assets
0.00%50M
0.00%50M
0.00%50M
0.00%50M
--50M
--50M
--50M
--50M
----
----
Investment real estate
-5.51%20.75M
-5.43%21.06M
-43.16%21.36M
-42.98%21.66M
-43.61%21.96M
-43.16%22.27M
-4.62%37.58M
-4.12%37.99M
45.23%38.95M
85.96%39.17M
Long-term equity investment
10.96%88.19M
9.14%90.25M
9.52%92.63M
3.86%93.26M
-51.75%79.48M
-21.95%82.69M
-20.29%84.58M
-16.25%89.8M
89.29%164.74M
28.19%105.94M
Fixed assets
----
10.67%952.36M
----
----
----
1.01%860.56M
----
2.49%885.39M
----
24.50%851.93M
Constru in process
----
157.70%13.85M
----
----
----
-89.07%5.37M
----
-84.82%3.87M
----
70.65%49.16M
Intangible assets
-2.22%174.92M
9.48%173.78M
9.18%176.87M
7.49%178.08M
41.36%178.9M
23.28%158.74M
24.70%162M
34.81%165.67M
2.83%126.55M
4.49%128.76M
Development expenditure
2,941.80%25.86M
--18.49M
--11.87M
--6.03M
2,266.35%850.05K
----
----
----
-98.52%35.92K
----
Goodwill
31.06%2B
34.82%1.96B
28.76%1.8B
18.07%1.65B
10.86%1.53B
5.07%1.46B
1.25%1.4B
1.25%1.4B
13.24%1.38B
19.77%1.39B
Long deferred expense
13.21%721.57M
9.53%706.17M
6.60%689.55M
3.94%654.72M
4.61%637.39M
5.60%644.71M
9.43%646.83M
6.63%629.9M
21.11%609.28M
34.03%610.55M
Deferred tax assets
17.10%115.47M
11.03%105.22M
-2.70%96.73M
-5.49%88.94M
24.74%98.61M
26.42%94.77M
66.12%99.42M
60.98%94.11M
28.99%79.06M
48.51%74.97M
Usufruct assets
2.33%3.07B
4.93%3.14B
-0.04%3.05B
-4.07%2.98B
1.92%3B
-0.87%2.99B
-2.41%3.05B
-2.71%3.1B
3.79%2.95B
10.78%3.02B
Other non current assets
-93.09%20.6M
-89.95%27.27M
-83.01%46.76M
-76.80%61.07M
-13.05%298.22M
-19.83%271.3M
-17.38%275.27M
-1.06%263.26M
34.73%342.97M
59.53%338.39M
Total non current assets
7.29%7.26B
9.38%7.26B
4.80%7B
0.49%6.75B
2.85%6.77B
0.54%6.64B
0.23%6.67B
1.15%6.72B
10.61%6.58B
19.14%6.61B
Total assets
4.96%17.13B
10.29%17.5B
6.85%17.54B
2.89%16.65B
8.30%16.32B
10.37%15.87B
13.23%16.42B
12.85%16.18B
12.07%15.07B
17.31%14.38B
Liabilities
Current liabilities
Short term loan
-4.09%495.53M
16.27%520.92M
15.05%520.64M
16.40%468.6M
41.50%516.67M
31.61%448.03M
154.66%452.53M
215.25%402.57M
1,021.62%365.14M
--340.41M
Notes payable and accounts payable
17.51%4.95B
25.18%4.99B
13.94%5.08B
0.24%4.34B
8.12%4.21B
12.42%3.99B
19.97%4.46B
13.74%4.33B
10.57%3.89B
13.93%3.55B
-Notes payable
21.78%1.69B
25.50%1.9B
-15.27%1.52B
4.93%1.78B
-1.93%1.39B
18.07%1.51B
26.48%1.79B
15.22%1.7B
24.59%1.41B
21.45%1.28B
-Accounts payable
15.41%3.26B
24.98%3.1B
33.58%3.56B
-2.77%2.56B
13.86%2.82B
9.23%2.48B
15.95%2.66B
12.81%2.63B
3.89%2.48B
10.09%2.27B
Contract liabilities
-30.76%80.53M
-11.85%91.57M
-49.84%74.62M
-31.55%101.12M
-20.79%116.29M
-27.30%103.88M
51.97%148.77M
54.11%147.74M
129.64%146.82M
153.93%142.89M
Advance receipts
-4.18%12.26M
-29.80%8.04M
2.56%9.77M
41.93%12.6M
33.81%12.79M
27.45%11.46M
1.94%9.52M
-4.74%8.88M
11.58%9.56M
14.91%8.99M
Salaries payable
-12.59%236.36M
-9.00%224.75M
-16.29%215.63M
-36.06%239.73M
15.04%270.39M
14.80%246.96M
29.35%257.6M
82.74%374.95M
14.98%235.04M
5.08%215.13M
Taxs payable
32.12%193.23M
50.69%209.23M
35.60%272.57M
64.84%412.72M
23.68%146.26M
21.09%138.85M
14.02%201.01M
52.59%250.38M
-12.85%118.25M
2.27%114.67M
Other payable (including interest and dividends)
11.01%450.16M
15.15%477.88M
25.46%544.97M
27.85%507.51M
-10.56%405.5M
9.07%415.02M
-6.85%434.37M
-12.99%396.97M
1.72%453.37M
85.27%380.5M
-Dividend payable
-59.10%8.44M
-67.67%8.44M
-67.90%8.68M
-67.90%8.68M
-23.65%20.64M
-3.39%26.11M
0.30%27.03M
0.30%27.03M
2,178.12%27.03M
2,178.12%27.03M
-Other payable
----
20.71%469.44M
----
----
----
10.03%388.91M
----
-13.82%369.94M
----
73.11%353.47M
Non current liabilities due within one year
26.29%1.01B
29.22%1.03B
36.37%997.12M
4.79%977.68M
5.61%796.71M
-17.37%795.47M
-23.46%731.21M
-8.19%932.97M
-17.52%754.41M
12.08%962.75M
Other current liabilities
629.14%213.39M
827.97%316.69M
288.39%56.25M
318.71%140.44M
144.72%29.27M
200.21%34.13M
125.96%14.48M
890.31%33.54M
430.82%11.96M
802.16%11.37M
Total current liabilities
17.39%7.63B
27.29%7.87B
15.86%7.77B
4.70%7.2B
8.61%6.5B
8.00%6.18B
15.56%6.71B
16.88%6.88B
12.37%5.99B
25.52%5.73B
Current liabilities
Long term loan
----
----
----
----
----
----
-94.12%2M
-94.86%1.8M
----
----
Deferred tax liabilities
-7.78%3.81M
-2.47%3.92M
-3.80%3.89M
-3.19%3.93M
17.03%4.13M
12.25%4.02M
5.95%4.04M
13.99%4.05M
--3.53M
--3.58M
Long term deferred income
-3.16%10.31M
0.64%11.04M
10.10%12.97M
9.41%13.3M
-16.28%10.65M
-14.94%10.97M
-8.43%11.78M
-8.87%12.15M
-5.58%12.72M
-22.33%12.9M
Lease liabilities
-10.90%1.61B
-11.59%1.65B
-15.34%1.63B
-11.64%1.55B
-3.15%1.81B
9.88%1.87B
6.95%1.92B
1.60%1.76B
20.19%1.87B
13.10%1.7B
Other non current liabilities
--1.24M
--1.24M
--1.24M
--1.24M
----
----
----
----
----
----
Total non current liabilities
-10.78%1.63B
-11.43%1.67B
-15.18%1.64B
-11.50%1.57B
-3.20%1.82B
9.70%1.88B
4.82%1.94B
-0.35%1.77B
16.95%1.89B
12.95%1.71B
Total liabilities
11.22%9.26B
18.26%9.54B
8.89%9.41B
1.37%8.77B
5.78%8.33B
8.39%8.06B
12.96%8.64B
12.87%8.65B
13.43%7.87B
22.38%7.44B
Shareholders equity
Paid-in capital
-0.00%596.01M
-0.00%596.01M
-0.00%596.01M
-0.00%596.01M
-0.01%596.02M
-0.01%596.02M
-0.03%596.02M
-0.03%596.02M
-0.02%596.07M
-0.02%596.07M
Capital reserve funds
0.95%2.14B
0.98%2.14B
0.02%2.14B
-0.16%2.14B
-1.96%2.12B
-1.86%2.12B
-0.67%2.14B
-0.46%2.15B
0.84%2.17B
0.96%2.16B
Surplus reserve funds
0.00%364.29M
0.00%364.29M
0.00%364.29M
0.00%364.29M
0.00%364.29M
0.00%364.29M
0.00%364.29M
0.00%364.29M
25.00%364.29M
25.00%364.29M
Retained profit
-1.72%4.7B
1.92%4.69B
6.85%4.89B
7.17%4.65B
19.49%4.78B
22.92%4.6B
24.19%4.57B
23.72%4.34B
17.06%4B
17.75%3.74B
Less:Treasury stock
3,628.26%110.66M
----
----
-81.31%4.24M
-87.27%2.97M
-87.27%2.97M
-61.13%18.21M
-51.58%22.69M
-52.14%23.32M
-52.14%23.32M
Other composite income
----
----
----
----
543.87%6.28M
932.68%6.3M
2,182.03%6.13M
111.42%6.19M
111.85%974.72K
44.14%609.84K
Shareholders equity without minority interests
-2.24%7.69B
1.38%7.79B
4.25%7.99B
4.31%7.75B
10.74%7.87B
12.33%7.69B
13.49%7.67B
12.90%7.43B
10.93%7.11B
11.09%6.84B
Minority interests
41.32%176M
46.85%168.57M
27.75%134.92M
29.18%131.04M
35.03%124.54M
24.93%114.8M
16.71%105.61M
7.00%101.44M
-8.65%92.23M
526.19%91.89M
Total shareholder equity
-1.56%7.87B
2.05%7.96B
4.57%8.13B
4.64%7.88B
11.05%7.99B
12.49%7.8B
13.53%7.77B
12.81%7.53B
10.62%7.2B
12.31%6.94B
Total liabilityies and equity
4.96%17.13B
10.29%17.5B
6.85%17.54B
2.89%16.65B
8.30%16.32B
10.37%15.87B
13.23%16.42B
12.85%16.18B
12.07%15.07B
17.31%14.38B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -2.71%3.24B15.85%3.6B9.23%3.91B4.67%3.68B21.06%3.33B61.85%3.11B116.87%3.58B57.11%3.51B29.76%2.75B-14.46%1.92B
Transactional financial assets -----------------40.65%8.36M-97.34%8.36M-98.68%8.36M-97.19%8.36M--14.08M--314.44M
Notes receivable and accounts receivable 12.27%1.9B18.21%1.89B18.91%2.01B-10.64%1.54B-2.30%1.69B-3.15%1.6B-8.02%1.69B28.00%1.73B16.71%1.73B37.50%1.65B
-Notes receivable 1,243.99%186.18M7,476.99%300.73M--48.63M11,676.09%107.54M--13.85M--3.97M------913.2K--------
-Accounts receivable 2.11%1.72B-0.34%1.59B16.04%1.96B-16.82%1.44B-3.10%1.68B-3.39%1.6B-8.02%1.69B27.94%1.73B16.71%1.73B37.50%1.65B
Other receivables (including interest and dividends) -5.03%338.73M18.50%328.74M16.01%331.78M0.03%284.13M18.53%356.69M38.10%277.41M45.79%285.99M37.46%284.04M36.93%300.92M23.04%200.87M
-Dividend receivable -49.15%780.77K-56.75%780.77K-23.80%780.77K-23.80%780.77K--1.54M--1.81M--1.02M--1.02M--------
-Other receivable ----19.00%327.96M------------37.21%275.6M----36.97%283.02M----23.04%200.87M
Advance payment 34.77%195.21M2.70%215.94M-48.76%142.41M-56.64%152.3M-5.96%144.85M-4.35%210.26M57.87%277.91M80.31%351.21M4.98%154.03M34.63%219.82M
Inventories 4.51%4B3.24%3.97B4.66%3.97B13.73%3.85B13.12%3.83B14.16%3.85B15.93%3.79B2.12%3.39B8.38%3.38B27.54%3.37B
Receivable financing -61.12%31.05M46.33%65.13M500.24%61.65M-77.47%10.69M98.94%79.85M37.62%44.51M-34.20%10.27M82.89%47.44M-52.87%40.14M-2.89%32.34M
Non-current assets due within one year ------0------219.66M------------------------
Other current assets 44.07%164.52M24.42%157.73M23.23%125.31M10.26%153.54M-0.40%114.19M115.87%126.77M61.70%101.69M112.61%139.25M-64.18%114.66M-77.40%58.73M
Total current assets 3.31%9.87B10.94%10.23B8.25%10.55B4.60%9.89B12.52%9.55B18.73%9.22B24.27%9.74B22.95%9.46B13.23%8.49B15.79%7.77B
Non Current assets
Other non-current financial assets 0.00%50M0.00%50M0.00%50M0.00%50M--50M--50M--50M--50M--------
Investment real estate -5.51%20.75M-5.43%21.06M-43.16%21.36M-42.98%21.66M-43.61%21.96M-43.16%22.27M-4.62%37.58M-4.12%37.99M45.23%38.95M85.96%39.17M
Long-term equity investment 10.96%88.19M9.14%90.25M9.52%92.63M3.86%93.26M-51.75%79.48M-21.95%82.69M-20.29%84.58M-16.25%89.8M89.29%164.74M28.19%105.94M
Fixed assets ----10.67%952.36M------------1.01%860.56M----2.49%885.39M----24.50%851.93M
Constru in process ----157.70%13.85M-------------89.07%5.37M-----84.82%3.87M----70.65%49.16M
Intangible assets -2.22%174.92M9.48%173.78M9.18%176.87M7.49%178.08M41.36%178.9M23.28%158.74M24.70%162M34.81%165.67M2.83%126.55M4.49%128.76M
Development expenditure 2,941.80%25.86M--18.49M--11.87M--6.03M2,266.35%850.05K-------------98.52%35.92K----
Goodwill 31.06%2B34.82%1.96B28.76%1.8B18.07%1.65B10.86%1.53B5.07%1.46B1.25%1.4B1.25%1.4B13.24%1.38B19.77%1.39B
Long deferred expense 13.21%721.57M9.53%706.17M6.60%689.55M3.94%654.72M4.61%637.39M5.60%644.71M9.43%646.83M6.63%629.9M21.11%609.28M34.03%610.55M
Deferred tax assets 17.10%115.47M11.03%105.22M-2.70%96.73M-5.49%88.94M24.74%98.61M26.42%94.77M66.12%99.42M60.98%94.11M28.99%79.06M48.51%74.97M
Usufruct assets 2.33%3.07B4.93%3.14B-0.04%3.05B-4.07%2.98B1.92%3B-0.87%2.99B-2.41%3.05B-2.71%3.1B3.79%2.95B10.78%3.02B
Other non current assets -93.09%20.6M-89.95%27.27M-83.01%46.76M-76.80%61.07M-13.05%298.22M-19.83%271.3M-17.38%275.27M-1.06%263.26M34.73%342.97M59.53%338.39M
Total non current assets 7.29%7.26B9.38%7.26B4.80%7B0.49%6.75B2.85%6.77B0.54%6.64B0.23%6.67B1.15%6.72B10.61%6.58B19.14%6.61B
Total assets 4.96%17.13B10.29%17.5B6.85%17.54B2.89%16.65B8.30%16.32B10.37%15.87B13.23%16.42B12.85%16.18B12.07%15.07B17.31%14.38B
Liabilities
Current liabilities
Short term loan -4.09%495.53M16.27%520.92M15.05%520.64M16.40%468.6M41.50%516.67M31.61%448.03M154.66%452.53M215.25%402.57M1,021.62%365.14M--340.41M
Notes payable and accounts payable 17.51%4.95B25.18%4.99B13.94%5.08B0.24%4.34B8.12%4.21B12.42%3.99B19.97%4.46B13.74%4.33B10.57%3.89B13.93%3.55B
-Notes payable 21.78%1.69B25.50%1.9B-15.27%1.52B4.93%1.78B-1.93%1.39B18.07%1.51B26.48%1.79B15.22%1.7B24.59%1.41B21.45%1.28B
-Accounts payable 15.41%3.26B24.98%3.1B33.58%3.56B-2.77%2.56B13.86%2.82B9.23%2.48B15.95%2.66B12.81%2.63B3.89%2.48B10.09%2.27B
Contract liabilities -30.76%80.53M-11.85%91.57M-49.84%74.62M-31.55%101.12M-20.79%116.29M-27.30%103.88M51.97%148.77M54.11%147.74M129.64%146.82M153.93%142.89M
Advance receipts -4.18%12.26M-29.80%8.04M2.56%9.77M41.93%12.6M33.81%12.79M27.45%11.46M1.94%9.52M-4.74%8.88M11.58%9.56M14.91%8.99M
Salaries payable -12.59%236.36M-9.00%224.75M-16.29%215.63M-36.06%239.73M15.04%270.39M14.80%246.96M29.35%257.6M82.74%374.95M14.98%235.04M5.08%215.13M
Taxs payable 32.12%193.23M50.69%209.23M35.60%272.57M64.84%412.72M23.68%146.26M21.09%138.85M14.02%201.01M52.59%250.38M-12.85%118.25M2.27%114.67M
Other payable (including interest and dividends) 11.01%450.16M15.15%477.88M25.46%544.97M27.85%507.51M-10.56%405.5M9.07%415.02M-6.85%434.37M-12.99%396.97M1.72%453.37M85.27%380.5M
-Dividend payable -59.10%8.44M-67.67%8.44M-67.90%8.68M-67.90%8.68M-23.65%20.64M-3.39%26.11M0.30%27.03M0.30%27.03M2,178.12%27.03M2,178.12%27.03M
-Other payable ----20.71%469.44M------------10.03%388.91M-----13.82%369.94M----73.11%353.47M
Non current liabilities due within one year 26.29%1.01B29.22%1.03B36.37%997.12M4.79%977.68M5.61%796.71M-17.37%795.47M-23.46%731.21M-8.19%932.97M-17.52%754.41M12.08%962.75M
Other current liabilities 629.14%213.39M827.97%316.69M288.39%56.25M318.71%140.44M144.72%29.27M200.21%34.13M125.96%14.48M890.31%33.54M430.82%11.96M802.16%11.37M
Total current liabilities 17.39%7.63B27.29%7.87B15.86%7.77B4.70%7.2B8.61%6.5B8.00%6.18B15.56%6.71B16.88%6.88B12.37%5.99B25.52%5.73B
Current liabilities
Long term loan -------------------------94.12%2M-94.86%1.8M--------
Deferred tax liabilities -7.78%3.81M-2.47%3.92M-3.80%3.89M-3.19%3.93M17.03%4.13M12.25%4.02M5.95%4.04M13.99%4.05M--3.53M--3.58M
Long term deferred income -3.16%10.31M0.64%11.04M10.10%12.97M9.41%13.3M-16.28%10.65M-14.94%10.97M-8.43%11.78M-8.87%12.15M-5.58%12.72M-22.33%12.9M
Lease liabilities -10.90%1.61B-11.59%1.65B-15.34%1.63B-11.64%1.55B-3.15%1.81B9.88%1.87B6.95%1.92B1.60%1.76B20.19%1.87B13.10%1.7B
Other non current liabilities --1.24M--1.24M--1.24M--1.24M------------------------
Total non current liabilities -10.78%1.63B-11.43%1.67B-15.18%1.64B-11.50%1.57B-3.20%1.82B9.70%1.88B4.82%1.94B-0.35%1.77B16.95%1.89B12.95%1.71B
Total liabilities 11.22%9.26B18.26%9.54B8.89%9.41B1.37%8.77B5.78%8.33B8.39%8.06B12.96%8.64B12.87%8.65B13.43%7.87B22.38%7.44B
Shareholders equity
Paid-in capital -0.00%596.01M-0.00%596.01M-0.00%596.01M-0.00%596.01M-0.01%596.02M-0.01%596.02M-0.03%596.02M-0.03%596.02M-0.02%596.07M-0.02%596.07M
Capital reserve funds 0.95%2.14B0.98%2.14B0.02%2.14B-0.16%2.14B-1.96%2.12B-1.86%2.12B-0.67%2.14B-0.46%2.15B0.84%2.17B0.96%2.16B
Surplus reserve funds 0.00%364.29M0.00%364.29M0.00%364.29M0.00%364.29M0.00%364.29M0.00%364.29M0.00%364.29M0.00%364.29M25.00%364.29M25.00%364.29M
Retained profit -1.72%4.7B1.92%4.69B6.85%4.89B7.17%4.65B19.49%4.78B22.92%4.6B24.19%4.57B23.72%4.34B17.06%4B17.75%3.74B
Less:Treasury stock 3,628.26%110.66M---------81.31%4.24M-87.27%2.97M-87.27%2.97M-61.13%18.21M-51.58%22.69M-52.14%23.32M-52.14%23.32M
Other composite income ----------------543.87%6.28M932.68%6.3M2,182.03%6.13M111.42%6.19M111.85%974.72K44.14%609.84K
Shareholders equity without minority interests -2.24%7.69B1.38%7.79B4.25%7.99B4.31%7.75B10.74%7.87B12.33%7.69B13.49%7.67B12.90%7.43B10.93%7.11B11.09%6.84B
Minority interests 41.32%176M46.85%168.57M27.75%134.92M29.18%131.04M35.03%124.54M24.93%114.8M16.71%105.61M7.00%101.44M-8.65%92.23M526.19%91.89M
Total shareholder equity -1.56%7.87B2.05%7.96B4.57%8.13B4.64%7.88B11.05%7.99B12.49%7.8B13.53%7.77B12.81%7.53B10.62%7.2B12.31%6.94B
Total liabilityies and equity 4.96%17.13B10.29%17.5B6.85%17.54B2.89%16.65B8.30%16.32B10.37%15.87B13.23%16.42B12.85%16.18B12.07%15.07B17.31%14.38B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+1.79%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+1.64%
Health China
Health China
Intraday+1.06%